Dr Ina Oehme's presentation - Development of a functional patient-derived 3D multicellular platform for realtime personalized drug sensitivity profiling in the pediatric precision oncology program INFORM
This was presented at the Zero Childhood Cancer National Symposium 2022.
The inaugural Zero Childhood Cancer Program (ZERO) National Symposium was held in Sydney recently, bringing together leading national and international experts at the cutting edge of cancer precision medicine research to explore the theme ‘Towards Precision Oncology for All’.
ZERO is Australia’s first and most comprehensive precision medicine program for children and young people with cancer. Led by Children’s Cancer Institute and Kids Cancer Centre at Sydney Children’s Hospital, Randwick, ZERO is partnered with national and international research institutions and major paediatric hospitals in Australia to advance research-driven clinical care and support better outcomes for all children with cancer. Find out more at www.zerochildhoodcancer.org.au.
